I don't have time to respond point by point to all of this, but I'll make a few points (come back to me with more bite-sized questions if you have any lingering concerns).The OP claimed the contribution indicated JB's expectation of a share price rise in the near term. Is it correct to interpret it as indeterminate of share price anticipation but just a function of nearing expirations?
Really? Since you can read my mind, how good are you in reading JB's?
According to the Proxy his option status, at 12/31/16 was:
Award Date..Exercisable..Un-Exercisable Un-Earned Strike..Expiration
a) 4/11/2016 10,599 52,999 —------------ 249.92 4/11/2026
b) 1/13/2014 55,000 -------------- 165,000 139.34 1/13/2024
c) 7/8/2013 1,050 —--------- —---------- 121.61 7/8/2023
d) 6/10/2013 700 —---------- —----------- 100.05 6/10/2023
e) 5/13/2013 700 ------------- —--------------- 87.80 5/13/2023
f) 4/8/2013 350 —----------- —------------- 41.83 4/8/2023
g) 3/11/2013 700 —---------- —----------- 39.10 3/11/2023
h) 2/11/2013 350 —--------- —------------- 38.42 2/11/2023
i) 6/11/2012 700 —----------- —------------ 29.12 6/11/2022
j) 2/13/2012 50,000 —------- —----------- 31.49 2/13/2022
k) 1/9/2012 350 —--------- —----------- 27.25 1/9/2022
l) 12/12/2011 350 —----------- —---------- 30.41 12/12/2021
m) 3/14/2011 350 —------------ —--------- 23.25 3/14/2021
n) 1/10/2011 50,000 —------- —--------- 28.45 1/10/2021
o) 9/13/2010 20,000 —------- —--------- 20.72 9/13/2020
p) 6/12/2010 2,450 —---------- —--------- 14.17 6/11/2017
q) 6/12/2010 116,650 —-------- —-------- 14.17 6/11/2017
The reason to sell/exercise the awards in p) and q) is obvious. But for the other ~12,000, why choose:
i) 4,209 of the 50,000 in n);
ii) 7,493 of the 50,000 in j);
iii) 270 of the 10,599 in a) ???
I see these were all reported as ISOs rather than Non-Qualifying awards, but why do an allocation rather than using all from the nearest expiration or the highest or lowest basis?
Do think the additional ~12,000 early exercise/sells may be related to the loans from the banking affiliates of the underwriting syndicates. SEC filings show JB's pledges of TSLA shares have been:
12/31/15 90,380
9/23/16 87,066
12/31/16 127,925
Director Denholm's "need" appears urgent. She sold 20,000 shares for $311.76 with a basis of $259.94 for a pre-tax gain of ~$1.04 million. Assuming an effective income and employment tax rate of about 55%, she netted about $467,000. Her rights would not have expired for over four years. In fairness, it was her first sale since appointment in August, 2014.
Someone may need to have a sit down with Kimbal; so far in less than the first five months of 2017 his exercise/sells on Form 4s have been:
DATE SHARES
5/3/17 2,500
4/11/17 2,191
4/3/17 2,500
3/1/17 2,500
2/1/17 2,500
1/3/17 2,500
So far, selling those ~14,700 shares netted Kimbal a pre-tax gain of $3.5+ million.
In 2016 Kimbal sold ~20,800 shares in 4 fillings for a net pre-tax gain of $4.1+ million
In 2015 Kimbal sold ~24,600 shares in 4 fillings for a net pre-tax gain of $5.1+ million
In 2014 Kimbal sold ~31,600 shares in 5 fillings (basis not clearly reported)
In 2013 Kimbal sold ~22,500 shares in 5 fillings (basis not clearly reported)
In 2012 Kimbal sold ~18,200 shares in 2 fillings (basis not clearly reported)
In 2011 Kimbal sold ~6,700 shares in 2 fillings (basis not clearly reported)
In 2010 Kimbal sold ~50,800 shares in 1 filling (basis not clearly reported)
Likely all and most of the latter two transactions were cashing in his pre-IPO investment, but the rest are not bad compensation for attending 6 to 12 BoD meetings/year. SEC filings show Kimbal's pledges of TSLA shares have been:
12/31/15 148,333
9/23/16 148,333
12/31/16 164,154
(Likely reflects the conversion of pledged SCTY shares to TSLA shares) Kimbal's form 4s show he generally sells down to around the shares pledged.
I get the role that option awards play in SV compensation and the "corporate handcuffs" aspect of options and RSUs. My concerns are:
1. No officer nor director ever bought shares in the secondary market (even in February 2016) and most have sold frequently, even though their rights do not expire for years--(Elon has bought in some of the follow-on equity offerings but that appears to be more about maintaining effective control as the largest, but still minority owner and to help market the offering while using a line of credit from the banking affiliates of the underwriting syndicate.)
2. None of the criteria for option awards have ever been based on achieving Net Income goals.
YMMV.
The tranche(s) being exercised is almost always solely driven by the executive's personal tax advisor. I don't often know why certain tranches are being exercised bc everyone has unique financial considerations, but it makes perfect sense to the tax guys. I'm not going to sift through the Outstanding Awards proxy tables (one of my least favorite to put together by the way, what a pain), but if he's focusing on ISOs the reason is most likely because ISOs are tax free (though factored into AMT). Add in the fact that there's charitable donations and possible pledging and you'll be spitting into the wind guessing what the point of it all is. I see no indications of someone trying to cash out or catch a top, however. I also don't see this as a bullish "price about to explode" transaction, either. It's just neutral (aside from the near-term expiry, that's obvious) and driven by personal needs/wants.
Everything you are saying about directors is a red herring and not applicable to what I said. You'll notice I limited all my comments to executives, not directors. Non-executive directors are not subject to the same institutional pressures that executives are. In fact, executives go out of their way to not tell directors what to do with company shares bc of the appearance of "meddling." Non-executive directors are usually held in very high regard and treated with kid gloves at all stages, even with a powerful CEO Chairman.
Thus, non-executive directors are all over the map with share transactions and there's nothing you can read into them. Some just hold forever. Some make a regular habit of selling (Kimball...) and the executives and certainly not the lawyers (me...) are going to say "ummm, Kimbal? Could you go ahead and stop selling so damn often? My phone is ringing off the hook from investors asking why he's selling (yes, these calls are common, and annoying) and my hands are getting tired from preparing Form 4s. kthxbai." Again, they have their own reasons. Most are for diversification and not getting overweighted in anything.
Officers and directors at heavily equity-based comp companies almost never buy on the open market. Why the hell would they? Comp at such places are often weighted 10% base salary, 15% bonus and 75% (or more) equity. You're telling me they should shift even more to equity? Also, the same institutional pressures apply. Everything is perceived to send a signal and they don't even want to send positive signals. They want to send no signals, ever. Elon is an obvious exception.
Options are an unusual vehicle for directors, though that's the culture at a SV startup. 60/40 mix of full-value shares and cash is most common. I'm not troubled by it.
You are concerned that options don't have net income goals? This proves to me you don't have deep executive compensation knowledge or experience. The vast VAST majority of option compensation (at least 95%) are not tied to ANY goals, at all. There is built-in motivation in the options themselves - they have no value at all unless the SP increases after the grant date. In fact, options are rapidly falling out of favor with companies bc many executives find them non-motivational (relative to RSAs/RSUs) even without additional performance conditions, due to the risk of them going to 0 (often without anything done on their part - macros can certainly make naked options be worthless and therefore non-motivational). Adding all the performance conditions just made them even more performance-based, in a very non-market (and shareholder-friendly) manner. Asking for anything more than that is madness. Especially since Tesla comp is insanely equity heavy at the top as it is. They are cashing in huge bc they have grown the SP 20 times over.
I guess this ended up longer than expected, sorry.